Edition:
United States

Novavax Inc (NVAX.O)

NVAX.O on Nasdaq

1.63USD
27 Feb 2017
Change (% chg)

$0.25 (+18.12%)
Prev Close
$1.38
Open
$1.41
Day's High
$1.63
Day's Low
$1.40
Volume
9,813,425
Avg. Vol
7,542,034
52-wk High
$8.49
52-wk Low
$1.16

Select another date:

Mon, Feb 27 2017

BRIEF-Novavax reports Q4 loss per share $0.21

* Novavax reports fourth quarter and year-end 2016 financial results

BRIEF-Novavax reports Q3 loss per share $0.24

* Q3 earnings per share view $-0.26 -- Thomson Reuters I/B/E/S

Novavax cuts jobs to push ahead with respiratory vaccine for elderly

Nov 9 Novavax Inc said on Wednesday it would cut 30 percent of its global workforce, or 164 jobs, to help fund the testing of its vaccine for a common respiratory virus in the elderly, about two months after failing a late-stage study.

Novavax vaccine for respiratory disease fails in late stage trial

Novavax Inc said on Thursday that its experimental vaccine for a serious infectious respiratory disease failed at the final stage of human testing, sending its stock plunging more than 80 percent.

Select another date:

More From Around the Web